Shinpoong Pharmaceutical Co., Ltd.
019170.KS
Get informed when a big investor buys or sells
+ FollowMarket Cap$505.71B
Close$
$20050.58
115.6% upside
Current Fair Value
115.6% upsideUndervalued by 115.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $505.71 Billion |
|---|---|
| Enterprise Value | $510.90 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $172 |
| Beta | 1.12 |
| Outstanding Shares | 53,699,569 |
Return
| Return on Equity | -0.29% |
|---|---|
| Return on Assets | -0.22% |
| Return on Invested Capital | 1.11% |
Valuation & Multiples
| P/E Ratio | -1024.08 |
|---|---|
| PEG | 296.77 |
| Price to Sales | 2.09 |
| Price to Book Ratio | 1.8 |
| Enterprise Value to Revenue | 2.14 |
| Enterprise Value to EBIT | 157.11 |
| Enterprise Value to Net Income | -627 |
| Total Debt to Enterprise | 0.1 |
| Debt to Equity | 0.19 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Shinpoong Pharmaceutical Co., Ltd.
815 employees
CEO: Jei-Man Ryu Shinpoong Pharmaceutical Co., Ltd. is a South Korean company that manufactures and distributes a broad spectrum of pharmaceutical products. Its portfolio includes both cephalosporin and penicillin antibiotics, alongside other finished me...